Labcorp Holdings Inc. (LH) Long-Term Debt to Capital Coefficient

Symbol and logo of brand labcorp.com (LH)

Labcorp Holdings Inc. (LH) operates within a fierce duopoly in the laboratory diagnostics market, leveraging dense logistics to squeeze out local players. This chart of the share price illustrates the dynamics of the company, whose metric stands at 0.73. The business relies on complex licensing barriers and long-term agreements with insurance funds, ensuring stable access to biomaterials.

Long-Term Debt to Capital: Labcorp (LH) for 07/04/2022 - 10/30/2026
Flagship merchandise of LabCorp

Scaling the network of qualified technicians and specialists at Labcorp Holdings Inc. (LH) requires significant capital expenditures in infrastructure and personnel development. The long-term debt-to-equity ratio measures the proportion of long-term loans within the financing structure, allowing investors to assess the balance between financial leverage and business stability, a trend clearly reflected in the long-term debt-to-equity dynamics.